Breakpoint Therapeutics sabotages DNA repair in cancer cells
The Hamburg-based Evotec spinout Breakpoint Therapeutics is working on cancer treatments that block the ability…
The Hamburg-based Evotec spinout Breakpoint Therapeutics is working on cancer treatments that block the ability…
A molecular patient database for Sjögren’s syndrome (SjS) and systemic lupus erythematosus (SLE) is to…
Chemical bioinformatics company, Adapsyn Bioscience Inc., and Evotec SE have entered into a strategic collaboration…
Construction of a biologics manufacturing facility commenced on Friday (September 16). It is being built…
A clinical and commercial manufacturing platform for small molecule therapeutics has expanded following an acquisition…
A joint venture to create the next generation of antimicrobials, along with actionable diagnostics to…
An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics…
German headquartered life science company Evotec SE has acquired 100% of the capital of Rigenerand…
Evotec and Sernova are set to join forces to advance a beta cell replacement therapy…
Here’s a list of the public European biotech companies that are worth more than a…
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the…
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…